Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

@article{Ankerst2014ProstateCP,
  title={Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.},
  author={Donna P. Ankerst and Josef Hoefler and Sebastian Bock and Phyllis J. Goodman and Andrew J. Vickers and Javier Augusto Hern{\'a}ndez and Lori Sokoll and Martin George Sanda and John T. Wei and Robin J. Leach and Ian M. Thompson},
  journal={Urology},
  year={2014},
  volume={83 6},
  pages={1362-7}
}
OBJECTIVE To modify the Prostate Cancer Prevention Trial risk calculator (PCPTRC) to predict low- vs high-grade (Gleason grade≥7) prostate cancer and incorporate percent free-prostate-specific antigen (PSA). METHODS Data from 6664 Prostate Cancer Prevention Trial placebo arm biopsies (5826 individuals), where prostate-specific antigen and digital rectal examination results were available within 1 year before the biopsy and PSA was ≤10 ng/mL, were used to develop a nominal logistic regression… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
40 Extracted Citations
14 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 40 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 14 references

Similar Papers

Loading similar papers…